Mounjaro
Productby Eli Lilly and Company
Heard in 38 episodes across 29 shows since Oct 2025
Mounjaro is Eli Lilly’s prescription injectable medicine containing tirzepatide, a dual GIP and GLP-1 receptor agonist. It is used with diet and exercise to improve blood-sugar control in people with type 2 diabetes; the podcast references primarily describe its strong diabetes-treatment sales and demand, while distinguishing it from Lilly’s obesity brand, Zepbound.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Mounjaro per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 15 | 0.13‰ | 1 |
| Aug 16 | 0.15‰ | 1 |
| Aug 21 | 0.08‰ | 1 |
| Aug 29 | 0.01‰ | 1 |
| Sep 3 | 0.03‰ | 2 |
| Sep 8 | 0.03‰ | 1 |
| Sep 13 | 0.04‰ | 3 |
| Sep 20 | 0.02‰ | 2 |
| Sep 21 | 0.03‰ | 1 |
| Sep 23 | 0.04‰ | 1 |
| Sep 25 | 0.04‰ | 1 |
| Oct 18 | 0.02‰ | 2 |
| Oct 20 | 0.03‰ | 1 |
| Oct 21 | 0.03‰ | 1 |
| Oct 25 | 0.02‰ | 1 |
| Oct 27 | 0.02‰ | 1 |
| Oct 29 | 0.04‰ | 3 |
| Oct 30 | 0.05‰ | 1 |
| Oct 31 | 0.07‰ | 2 |
| Nov 1 | 0.07‰ | 1 |
| Nov 8 | 0.02‰ | 2 |
| Nov 9 | 0.02‰ | 1 |
Email alert
Email me when Mounjaro comes up on a podcast
One email a week at most, with the new episodes that mention Mounjaro. Free, no account needed, unsubscribe in one click.
What experts have said about Mounjaro
3 statements · 3 positive
Sam Tallent quit drinking and then began taking Mounjaro for weight loss.
“I quit drinking and then I got on Manjaro.”
Open the episode · #2575 - Sam TallentListen at 1:38:21
Eli Lilly’s Mounjaro is currently the world’s best-selling drug.
“Munjaro, which is Eli, is now the world's best selling drug.”
Open the episode · Dating apps are dying, is Eli Lilly still a buy & Pimp My Portfolio with Owen RaskListen at 21:24
Mounjaro users lose 21% of body weight on average annually.
“the average person who takes that loses 21% of their body weight in a year.”
Open the episode · Best of Big Technology: How Ozempic Changes Our Bodies, Minds, and Economy — With Johann HariListen at 17:30
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
38 episodes featuring Mounjaro, newest first
- Nov 9, 2026
GLP-1 drugs sharpen pregnancy’s unanswered questionsShort WaveNov 9, 2026 - Nov 8, 2026
Growth investors reassess AI bets and portfolio resilienceEquity Mates Investing PodcastNov 8, 2026 - Nov 3, 2026
Sam Tallent weighs comedy’s purpose against an automated futureThe Joe Rogan ExperienceNov 3, 2026 - Nov 1, 2026
Investors test Novo, Moody’s, and Deckers against bear casesThe Investor's Podcast (We Study Billionaires) - The Investor’s Podcast NetworkNov 1, 2026 - Oct 31, 2026
Bitcoin absorbs a major hack as AI reshapes trust and marketsThe Pomp PodcastOct 31, 2026 - Oct 30, 2026
Amazon and Intel Renew Pressure on Tech StocksSchwab Market Update AudioOct 30, 2026